Provides herbal products for tobacco cessation, organ repair, and stress management.
Annual revenue - Latest available
Total funding $60,152 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Smotect

Smotect is a company based in Mumbai (India) by Gurseet Singh. It operates as a D2C and B2C. Smotect has raised $60.15 thousand across 2 funding rounds from investors including Anupam Mittal. Smotect offers products and services including Smotect Natural Tablets and Smotect Azaadi.

  • Headquarter Mumbai, India
  • Founders Gurseet Singh
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Smotect Private Limited
  • Date of Incorporation 22 Feb, 2023
  • Jurisdiction Goregaon West, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $60.15 K (USD)

    in 2 rounds

  • Latest Funding Round
    $60.15 K (USD), Debt – Conventional

    Mar 21, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Smotect

Smotect offers a comprehensive portfolio of products and services, including Smotect Natural Tablets and Smotect Azaadi.

Primary

Nicotine-free formula to reduce tobacco cravings and repair organs.

Herbal product for quitting tobacco and managing withdrawal symptoms.

Funding Insights of Smotect

Smotect has successfully raised a total of $60.15K across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $60.15 thousand completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Debt – Conventional — $60,152
  • First Round

    (21 Mar 2024)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2024 Amount Angel Round - Smotect Valuation

investors

Mar, 2024 Amount Debt – Conventional - Smotect Valuation

investors

Investors in Smotect

Smotect has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Anupam Mittal.

All
Angel
Investor Description Founded Year Domain Location

Anupam Mittal

Founder of Shaadi.com, angel investor, Shark Tank India judge
Founded Year Domain Location

Investments & Acquisitions by Smotect

Investments

Financial Statements - Smotect

Smotect Comparisons

+
Add Comparison
Available on Premium

Competitors of Smotect

Latest news on Smotect

Frequently Asked Questions about Smotect

Smotect is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Gurseet Singh is the current CEO of Smotect. They have also founded this company.

Smotect is a funded company, having raised a total of $60.15K across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $60.15K, raised on Mar 21, 2024.

Smotect develops nicotine-free herbal tablets and supplements to assist tobacco users in quitting by reducing nicotine dependence and restoring organ health, such as lungs and heart. It uses natural ingredients like Ashwagandha and Tulsi for anti-stress and lung protection effects. Based in Mumbai, India, the company conducts clinical trials and offers guided sessions to support users journeys, focusing on evidence-based wellness solutions.

Smotect offers Smotect Natural Tablets and Smotect Azaadi.

Smotect has 1 investor. Key investors include Anupam Mittal.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available